Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study.
暂无分享,去创建一个
F. Ugo | A. Delitala | A. Margonato | P. Mazzone | P. Bella | M. Montorfano | F. Moroni | Marco Barbierato | F. Ronco | G. Casu | A. Beneduce | F. Rametta | G. Boccuzzi | G. D'Angelo | F. Simonetto | V. Magni | G. Lorenzoni | P. Merella | M. Barbierato | G. D’Angelo
[1] Jeroen J. Bax,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.
[2] A. Camm,et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[3] Hugh Calkins,et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. , 2019, Circulation.
[4] M. García-Fernández,et al. Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[5] S. Kische,et al. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage , 2019, Circulation. Arrhythmia and electrophysiology.
[6] P. Berne,et al. Left Atrial Appendage Occlusion in High Bleeding Risk Patients , 2019, Journal of interventional cardiology.
[7] H. Huttner,et al. Management of oral anticoagulation after intracerebral hemorrhage , 2019, International journal of stroke : official journal of the International Stroke Society.
[8] P. Berne,et al. Nonvalvular atrial fibrillation in high-hemorrhagic-risk patients: state of the art of percutaneous left atrial appendage occlusion , 2019, Journal of cardiovascular medicine.
[9] V. Reddy,et al. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes , 2018, Circulation.
[10] G. Lip,et al. Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study. , 2018, International journal of cardiology.
[11] S. Kische,et al. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial. , 2017, Heart rhythm.
[12] M. Rosenqvist,et al. Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up study. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[13] B. Meier,et al. Patients with intracranial bleeding and atrial fibrillation treated with left atrial appendage occlusion: Results from the Amplatzer Cardiac Plug registry. , 2017, International journal of cardiology.
[14] S. Olindo,et al. Left Atrial Appendage Closure in Patients with Atrial Fibrillation and Previous Intracerebral Hemorrhage. , 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[15] Dhanunjaya R. Lakkireddy,et al. Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[16] P. Kirchhof,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European heart journal.
[17] J. Saw,et al. Left Atrial Appendage Closure for Atrial Fibrillation Is Safe and Effective After Intracranial or Intraocular Hemorrhage. , 2016, The Canadian journal of cardiology.
[18] B. Meier,et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[19] G. Lip,et al. Recalibration of the HAS-BLED Score: Should Hemorrhagic Stroke Account for One or Two Points? , 2016, Chest.
[20] S. Greenberg,et al. Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage. , 2015, JAMA.
[21] C. Anderson,et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2015, Stroke.
[22] Saibal Kar,et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. , 2014, JAMA.
[23] D. Krieger,et al. European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage , 2014, International journal of stroke : official journal of the International Stroke Society.
[24] D. Singer,et al. Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. , 2014, American heart journal.
[25] R. Veltkamp,et al. Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage , 2014, Neurology.
[26] E. Antman,et al. Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.
[27] Michael Tin Chung Poon,et al. Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[28] C. Cannon,et al. Triple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting , 2013, Clinical cardiology.
[29] M. Wallander,et al. Mortality after hemorrhagic stroke , 2013, Neurology.
[30] Petr Neuzil,et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). , 2013, Journal of the American College of Cardiology.
[31] D. Atar,et al. Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.
[32] G. Breithardt,et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.
[33] Gregory Y H Lip,et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.
[34] C. Anderson,et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2010, Stroke.
[35] Gregory Y H Lip,et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.
[36] S. Yusuf,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[37] Salim Yusuf,et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[38] T. Wilkinson,et al. The risk of recurrent stroke after intracerebral haemorrhage , 2007, Journal of Neurology, Neurosurgery & Psychiatry.
[39] M. Woodward,et al. Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial , 2006, Stroke.
[40] D. Singer,et al. Can Patients Be Anticoagulated After Intracerebral Hemorrhage?: A Decision Analysis , 2003, Stroke.
[41] J. Odell,et al. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. , 1996, The Annals of thoracic surgery.